Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

RSS icon

JAMA: Will physician financial transparency offer Sunshine or shade?

As a means to dismember conflicts of interest within medicine, the Centers for Medicare & Medicaid Services (CMS)  now requires greater financial transparency between industry and physicians. Thanks to the Sunshine Act included as a provision of the Patient Protection and Affordable Care Act, industry will be required to divulge payments to physicians and academic medical centers on public websites. Two viewpoints published online Feb. 14 in the Journal of the American Medical Association questioned the rules feasibility and benefit.

Study: Biomarker could predict Alzheimers disease

A team of University of California, Los Angeles scientists who developed a chemical marker to help assess the neurological changes associated with cognitive impairment and dementia have found the brain-imaging tool effectively tracked and predicted cognitive decline over a two-year period, according to a study published in the February issue of Archives of Neurology.

SNM moves closer to changing its name

During the SNM [Society of Nuclear Medicine] House of Delegates meeting held Jan. 26-29 in Orlando, Fla., at the Mid-Winter meeting, the body approved a proposed amendment to the SNM bylaws that would change the name of the association to the Society of Nuclear Medicine and Molecular Imaging.

HeartWare has its day with FDA panel on April 25

The FDA's Circulatory System Devices Panel will review HeartWare International's premarket approval application for the HeartWare Ventricular Assist System on April 25.

AJR: Confusion reigns over recommendations for high-risk breast lesions

Disagreement over management of four high-risk breast lesionslobular neoplasia, benign papilloma, radial scar and flat epithelial atypiademonstrate the need for a prospective trial as current recommendations are not well substantiated, according to an article published in the February issue of the American Journal of Roentgenology.

Velomedix nets IDE to study hypothermia in acute MI patients

Velomedix, a clinical-stage medical device company, has received Investigational Device Exemption (IDE) approval from the FDA to evaluate the use of therapeutic hypothermia for the treatment of patients suffering an acute MI.

FDA clears Siemens' Biograph mCT PET/CT features

The FDA has cleared features associated with Siemens Healthcare's Biograph mCT PET/CT scanner, which can measure metabolic processes and data quantification, including the assessment of neurological disease, cancerous tissue and cardiac blood flow.

FDA green-lights Konica wireless DR

The FDA has cleared Konica Minoltas Aero DR wireless flat panel detector.

Displaying 7073 - 7080 of 23568

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.